|
Ataluren for Treating Duchenne Muscular Dystrophy with a Nonsense Mutation in the Dystrophin Gene Policy Position Statement (PP118), July 2023 (PDF, 217Kb)
|
|
Atidarsagene Autotemcel for Treating Metachromatic Leukodystrophy in Children, Policy Position Statement, (PP257), April 2023 (PDF, 180Kb)
|
|
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency (PP281) February 2027 (PDF, 212Kb)
|
|
Selective Dorsal Rhizotomy (SDR) for the treatment of spasticity in cerebral palsy in children aged 3-9 years, Policy Position Statement (PP245), March 2024 (PDF, 975Kb)
|
|
Specialised Paediatric Neurological Rehabilitation, Commissioning Policy (CP160), November 2024 (PDF, 359Kb)
|